Quantitative susceptibility mapping at 7 T in COVID-19: brainstem effects and outcome associations
Brain · 03.12.2024 · 147 (12) · 4121-4130
DOI: 10.1093/brain/awae215 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, online erschienen am 07.10.2024. Verfasst von Catarina Rua und 22 weiteren Autor:innen. Beteiligte Einrichtung: Wolfson Brain Imaging Centre, University of Cambridge, Cambridge CB2 0QQ, UK. Hauptthemen laut MEDLINE: COVID-19, Brain Stem, Magnetic Resonance Imaging. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIHR Oxford Health Biomedical Research Centre, NIHR, BHF Centre of Research Excellence, Oxford.
Abstract (Originalsprache)
Post-mortem studies have shown that patients dying from severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection frequently have pathological changes in their CNS, particularly in the brainstem. Many of these changes are proposed to result from para-infectious and/or post-infection immune responses. Clinical symptoms such as fatigue, breathlessness, and chest pain are frequently reported in post-hospitalized coronavirus disease 2019 (COVID-19) patients. We propose that these symptoms are in part due to damage to key neuromodulatory brainstem nuclei. While brainstem involvement has been demonstrated in the acute phase of the illness, the evidence of long-term brainstem change on MRI is inconclusive. We therefore used ultra-high field (7 T) quantitative susceptibility mapping (QSM) to test the hypothesis that brainstem abnormalities persist in post-COVID patients and that these are associated with persistence of key symptoms. We used 7 T QSM data from 30 patients, scanned 93–548 days after hospital admission for COVID-19 and compared them to 51 age-matched controls without prior history of COVID-19 infection. We correlated the patients’ QSM signals with disease severity (duration of hospital admission and COVID-19 severity scale), inflammatory response during the acute illness (C-reactive protein, D-dimer and platelet levels), functional recovery (modified Rankin scale), depression (Patient Health Questionnaire-9) and anxiety (Generalized Anxiety Disorder-7). In COVID-19 survivors, the MR susceptibility increased in the medulla, pons and midbrain regions of the brainstem. Specifically, there was increased susceptibility in the inferior medullary reticular formation and the raphe pallidus and obscurus. In these regions, patients with higher tissue susceptibility had worse acute disease severity, higher acute inflammatory markers, and significantly worse functional recovery. This study contributes to understanding the long-term effects of COVID-19 and recovery. Using non-invasive ultra-high field 7 T MRI, we show evidence of brainstem pathophysiological changes associated with inflammatory processes in post-hospitalized COVID-19 survivors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Wolfson Brain Imaging Centre, University of Cambridge, Cambridge CB2 0QQ, UK.
- University of Cambridge Centre for Parkinson-plus, University of Cambridge, Cambridge CB2 0QQ, UK.
- Invicro, Invicro London, Burlington Danes Building, Imperial College London, London W12 0NN, UK.
- Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK.
- Division of Cardiovascular Medicine, Radcliffe Department of Medicine and Oxford University Hospitals NHS Foundation Trust, University of Oxford, Oxford OX3 9DU, UK.
- Division of Anaesthesia, University of Cambridge, Cambridge CB2 0QQ, UK.
ORCID-Profile: Betty Raman, Virginia F J Newcombe, Emmanuel A Stamatakis, William T Clarke, Stefan Neubauer, Karen D Ersche, David K Menon
Förderung
- NIHR Oxford Health Biomedical Research Centre
- NIHR
- BHF Centre of Research Excellence, Oxford
- University of Oxford Medical Sciences Division COVID-19 Research Response Fund
- NIHR Cambridge Biomedical Research Centre
- Wellcome Trust
- NIHR Oxford Biomedical Research Centre
- Academy of Medical Sciences/The Health Foundation Clinician Scientist Fellowship
Zitieren
APA
Rua, C., Raman, B., Rodgers, C. T., Newcombe, V. F. J., Manktelow, A., Chatfield, D. A., Sawcer, S. J., Outtrim, J. G., Lupson, V. C., Stamatakis, E. A., Williams, G. B., Clarke, W. T., Qiu, L., Ezra, M., McDonald, R., Clare, S., Cassar, M., Neubauer, S., Ersche, K. D., …, & Rowe, J. B. (2024). Quantitative susceptibility mapping at 7 T in COVID-19: brainstem effects and outcome associations. Brain, 147(12), 4121-4130. https://doi.org/10.1093/brain/awae215
Vancouver
Rua C, Raman B, Rodgers CT, Newcombe VFJ, Manktelow A, Chatfield DA, et al. Quantitative susceptibility mapping at 7 T in COVID-19: brainstem effects and outcome associations. Brain. 2024;147(12):4121-4130. doi:10.1093/brain/awae215
BibTeX
@article{Rua2024,
author = {Rua, Catarina and Raman, Betty and Rodgers, Christopher T and Newcombe, Virginia F J and Manktelow, Anne and Chatfield, Doris A and Sawcer, Stephen J and Outtrim, Joanne G and Lupson, Victoria C and Stamatakis, Emmanuel A and Williams, Guy B and Clarke, William T and Qiu, Lin and Ezra, Martyn and McDonald, Rory and Clare, Stuart and Cassar, Mark and Neubauer, Stefan and Ersche, Karen D and Bullmore, Edward T and Menon, David K and Pattinson, Kyle and Rowe, James B},
title = {Quantitative susceptibility mapping at 7 T in COVID-19: brainstem effects and outcome associations},
journal = {Brain},
year = {2024},
volume = {147},
number = {12},
pages = {4121--4130},
doi = {10.1093/brain/awae215}
}
EUVIMED